1. Home
  2. CBLL vs HTD Comparison

CBLL vs HTD Comparison

Compare CBLL & HTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CBLL
  • HTD
  • Stock Information
  • Founded
  • CBLL 2014
  • HTD 2004
  • Country
  • CBLL United States
  • HTD United States
  • Employees
  • CBLL N/A
  • HTD N/A
  • Industry
  • CBLL
  • HTD Finance Companies
  • Sector
  • CBLL
  • HTD Finance
  • Exchange
  • CBLL Nasdaq
  • HTD Nasdaq
  • Market Cap
  • CBLL 710.2M
  • HTD 850.4M
  • IPO Year
  • CBLL 2024
  • HTD N/A
  • Fundamental
  • Price
  • CBLL $12.06
  • HTD $24.61
  • Analyst Decision
  • CBLL Strong Buy
  • HTD
  • Analyst Count
  • CBLL 6
  • HTD 0
  • Target Price
  • CBLL $33.00
  • HTD N/A
  • AVG Volume (30 Days)
  • CBLL 353.5K
  • HTD 92.3K
  • Earning Date
  • CBLL 08-05-2025
  • HTD 01-01-0001
  • Dividend Yield
  • CBLL N/A
  • HTD 8.59%
  • EPS Growth
  • CBLL N/A
  • HTD N/A
  • EPS
  • CBLL N/A
  • HTD N/A
  • Revenue
  • CBLL $77,419,000.00
  • HTD N/A
  • Revenue This Year
  • CBLL $33.98
  • HTD N/A
  • Revenue Next Year
  • CBLL $28.82
  • HTD N/A
  • P/E Ratio
  • CBLL N/A
  • HTD N/A
  • Revenue Growth
  • CBLL 42.16
  • HTD N/A
  • 52 Week Low
  • CBLL $10.01
  • HTD $16.17
  • 52 Week High
  • CBLL $32.75
  • HTD $22.13
  • Technical
  • Relative Strength Index (RSI)
  • CBLL 35.66
  • HTD 61.04
  • Support Level
  • CBLL $11.35
  • HTD $24.33
  • Resistance Level
  • CBLL $12.60
  • HTD $24.58
  • Average True Range (ATR)
  • CBLL 0.78
  • HTD 0.20
  • MACD
  • CBLL 0.03
  • HTD -0.03
  • Stochastic Oscillator
  • CBLL 17.97
  • HTD 80.00

About CBLL CeriBell Inc. Common Stock

CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.

About HTD John Hancock Tax Advantaged Dividend Income Fund of Beneficial Interest

John Hancock Tax-advantaged Div Inc Fd is a closed-end, diversified management investment company. Its investment objective is to provide a high after-tax total return from dividend income and capital appreciation. The fund's portfolio composition consists of common stocks, preferred securities, corporate bonds, convertible bonds, and short-term investments. Its sector composition comprises utilities, financials, energy, telecommunication services, industrials, healthcare, real estate, consumer discretionary and short-term investments.

Share on Social Networks: